{
    "info": {
        "nct_id": "NCT06139107",
        "official_title": "RADIANT Study: Pre-op Radiation With Abemaciclib Andletrozole in Early Stage Breast Cancer",
        "inclusion_criteria": "* Histologically and/or cytologically confirmed diagnosis of invasive (ductal, lobular or mixed histology), Clinically inapparent tumor that is not palpable. (cT1-T2N0)disease. Minimum tumor size of 1.5 cm\n* Expression of ER or progesterone receptors (PR)and negative expression of HER2 per American Society of Clinical Oncology, (ASCO) Common Alerting Protocol (CAP) guidelines\n* Oncotype diagnosis (DX) Breast Recurrence score of less than 25 on core biopsy specimen\n* Post-menopausal status defined:\n* age <60 with amenorrhea for at least 12 months in the absence of prior chemotherapy, tamoxifen, toremifene, or ovarian suppression and estradiol and FSH (follicle stimulating hormone) in postmenopausal range.\n* No clinical suspicion of metastasis disease\n* Eastern Cooperative Oncology Group (ECOG) performance status of follicle stimulating hormone (PFS) ≤2\n* Eligible to undergo surgery, either lumpectomy or mastectomy for local treatment of the breast cancer\n* Able to swallow oral medications\n* Adequate organ function for all of the following:\n\nAbsolute Neutrophil (ANC) >1.5 x 10/L Platelets >100 x 10/L Hemoglobin >8 g/dL - May receive erythrocyte transfusions to achieve this level Total Bilirubin <1.5 x Upper Limit of Normal (ULN) Alanine Aminotransferase (ATL) and Aspartate Aminotransferase (AST) <3 x ULN\n\n* HR positive/HER2 -negative breast cancers are allowed as long as no other exclusions exist\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 60 Years",
        "exclusion_criteria": "* History of ipsilateral breast cancer\n* Prior treatment with CDK4/6 inhibitors or aromatase inhibitors\n* History of chest wall or ipsilateral breast radiation\n* Inflammatory breast cancer\n* Needs neoadjuvant chemotherapy\n* Presence of distant metastatic disease\n* Contraindication for surgery\n* Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)\n* Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk if he/she were to participate in the study\n* Life expectancy < 12 weeks\n* History of allergy or hypersensitivity to any of the study drugs\n* Any significant medical condition, laboratory abnormality, or psychiatric illness\n* Serious and/or uncontrolled preexisting medical condition\n* Has had major surgery within 14 days prior to enrollment\n* Has received an experimental treatment in a clinical trial within the last 30 days or 5 half-lives, whichever is longer, prior to enrollment, or is currently enrolled in any other type of medical research\n* Has active systemic bacterial infection\n* Personal history of any of the following conditions: syncope of cardiovascular etiology, ventricular arrhythmia of pathological origin (including, but not limited to, ventricular tachycardia and ventricular fibrillation), or sudden cardiac arrest",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Able to swallow oral medications",
            "criterions": [
                {
                    "exact_snippets": "Able to swallow oral medications",
                    "criterion": "ability to swallow oral medications",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function for all of the following:",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* HR positive/HER2 -negative breast cancers are allowed as long as no other exclusions exist",
            "criterions": [
                {
                    "exact_snippets": "HR positive/HER2 -negative breast cancers are allowed",
                    "criterion": "breast cancer subtype",
                    "requirements": [
                        {
                            "requirement_type": "hormone receptor status",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "HER2 status",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Post-menopausal status defined:",
            "criterions": [
                {
                    "exact_snippets": "Post-menopausal status defined:",
                    "criterion": "post-menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "post-menopausal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 60 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 60 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Absolute Neutrophil (ANC) >1.5 x 10/L Platelets >100 x 10/L Hemoglobin >8 g/dL - May receive erythrocyte transfusions to achieve this level Total Bilirubin <1.5 x Upper Limit of Normal (ULN) Alanine Aminotransferase (ATL) and Aspartate Aminotransferase (AST) <3 x ULN",
            "criterions": [
                {
                    "exact_snippets": "Absolute Neutrophil (ANC) >1.5 x 10/L",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "x 10/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Platelets >100 x 10/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "x 10/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Hemoglobin >8 g/dL - May receive erythrocyte transfusions to achieve this level",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 8,
                                "unit": "g/dL"
                            }
                        },
                        {
                            "requirement_type": "transfusion permitted",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Total Bilirubin <1.5 x Upper Limit of Normal (ULN)",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Alanine Aminotransferase (ATL) and Aspartate Aminotransferase (AST) <3 x ULN",
                    "criterion": "alanine aminotransferase (ALT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Alanine Aminotransferase (ATL) and Aspartate Aminotransferase (AST) <3 x ULN",
                    "criterion": "aspartate aminotransferase (AST)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Expression of ER or progesterone receptors (PR)and negative expression of HER2 per American Society of Clinical Oncology, (ASCO) Common Alerting Protocol (CAP) guidelines",
            "criterions": [
                {
                    "exact_snippets": "Expression of ER or progesterone receptors (PR)",
                    "criterion": "estrogen receptor (ER) or progesterone receptor (PR) expression",
                    "requirements": [
                        {
                            "requirement_type": "expression",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "negative expression of HER2 per American Society of Clinical Oncology, (ASCO) Common Alerting Protocol (CAP) guidelines",
                    "criterion": "HER2 expression",
                    "requirements": [
                        {
                            "requirement_type": "expression",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "guideline",
                            "expected_value": "ASCO CAP"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically and/or cytologically confirmed diagnosis of invasive (ductal, lobular or mixed histology), Clinically inapparent tumor that is not palpable. (cT1-T2N0)disease. Minimum tumor size of 1.5 cm",
            "criterions": [
                {
                    "exact_snippets": "Histologically and/or cytologically confirmed diagnosis of invasive (ductal, lobular or mixed histology)",
                    "criterion": "breast cancer histology",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histological",
                                "cytological"
                            ]
                        },
                        {
                            "requirement_type": "invasiveness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "histological subtype",
                            "expected_value": [
                                "ductal",
                                "lobular",
                                "mixed"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Clinically inapparent tumor that is not palpable",
                    "criterion": "tumor palpability",
                    "requirements": [
                        {
                            "requirement_type": "palpability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "(cT1-T2N0)disease",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "T stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "T"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "T"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "N stage",
                            "expected_value": "N0"
                        }
                    ]
                },
                {
                    "exact_snippets": "Minimum tumor size of 1.5 cm",
                    "criterion": "tumor size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of follicle stimulating hormone (PFS) ≤2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status ... ≤2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No clinical suspicion of metastasis disease",
            "criterions": [
                {
                    "exact_snippets": "No clinical suspicion of metastasis disease",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "clinical suspicion",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Oncotype diagnosis (DX) Breast Recurrence score of less than 25 on core biopsy specimen",
            "criterions": [
                {
                    "exact_snippets": "Oncotype diagnosis (DX) Breast Recurrence score of less than 25",
                    "criterion": "Oncotype DX Breast Recurrence score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 25,
                                "unit": ""
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "on core biopsy specimen",
                    "criterion": "specimen type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "core biopsy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eligible to undergo surgery, either lumpectomy or mastectomy for local treatment of the breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Eligible to undergo surgery, either lumpectomy or mastectomy",
                    "criterion": "surgical eligibility",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "surgery type",
                            "expected_value": [
                                "lumpectomy",
                                "mastectomy"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "for local treatment of the breast cancer",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment intent",
                            "expected_value": "local treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* age <60 with amenorrhea for at least 12 months in the absence of prior chemotherapy, tamoxifen, toremifene, or ovarian suppression and estradiol and FSH (follicle stimulating hormone) in postmenopausal range.",
            "criterions": [
                {
                    "exact_snippets": "age <60",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 60,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "amenorrhea for at least 12 months",
                    "criterion": "amenorrhea",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "in the absence of prior chemotherapy, tamoxifen, toremifene, or ovarian suppression",
                    "criterion": "prior chemotherapy, tamoxifen, toremifene, or ovarian suppression",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "estradiol and FSH (follicle stimulating hormone) in postmenopausal range",
                    "criterion": "estradiol",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "postmenopausal range"
                        }
                    ]
                },
                {
                    "exact_snippets": "estradiol and FSH (follicle stimulating hormone) in postmenopausal range",
                    "criterion": "FSH (follicle stimulating hormone)",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "postmenopausal range"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Has active systemic bacterial infection",
            "criterions": [
                {
                    "exact_snippets": "Has active systemic bacterial infection",
                    "criterion": "systemic bacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of distant metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "Presence of distant metastatic disease",
                    "criterion": "distant metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any significant medical condition, laboratory abnormality, or psychiatric illness",
            "criterions": [
                {
                    "exact_snippets": "Any significant medical condition",
                    "criterion": "medical condition",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "laboratory abnormality",
                    "criterion": "laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness",
                    "criterion": "psychiatric illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy < 12 weeks",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy < 12 weeks",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Personal history of any of the following conditions: syncope of cardiovascular etiology, ventricular arrhythmia of pathological origin (including, but not limited to, ventricular tachycardia and ventricular fibrillation), or sudden cardiac arrest",
            "criterions": [
                {
                    "exact_snippets": "Personal history of ... syncope of cardiovascular etiology",
                    "criterion": "syncope of cardiovascular etiology",
                    "requirements": [
                        {
                            "requirement_type": "personal history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Personal history of ... ventricular arrhythmia of pathological origin (including, but not limited to, ventricular tachycardia and ventricular fibrillation)",
                    "criterion": "ventricular arrhythmia of pathological origin",
                    "requirements": [
                        {
                            "requirement_type": "personal history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Personal history of ... sudden cardiac arrest",
                    "criterion": "sudden cardiac arrest",
                    "requirements": [
                        {
                            "requirement_type": "personal history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk if he/she were to participate in the study",
            "criterions": [
                {
                    "exact_snippets": "Any condition ... places the subject at unacceptable risk if he/she were to participate in the study",
                    "criterion": "any condition",
                    "requirements": [
                        {
                            "requirement_type": "risk assessment",
                            "expected_value": "unacceptable risk if participating in the study"
                        }
                    ]
                },
                {
                    "exact_snippets": "presence of laboratory abnormalities ... places the subject at unacceptable risk if he/she were to participate in the study",
                    "criterion": "laboratory abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "risk assessment",
                            "expected_value": "unacceptable risk if participating in the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has received an experimental treatment in a clinical trial within the last 30 days or 5 half-lives, whichever is longer, prior to enrollment, or is currently enrolled in any other type of medical research",
            "criterions": [
                {
                    "exact_snippets": "Has received an experimental treatment in a clinical trial within the last 30 days or 5 half-lives, whichever is longer, prior to enrollment",
                    "criterion": "receipt of experimental treatment in a clinical trial",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 30,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "is currently enrolled in any other type of medical research",
                    "criterion": "current enrollment in other medical research",
                    "requirements": [
                        {
                            "requirement_type": "enrollment status",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serious and/or uncontrolled preexisting medical condition",
            "criterions": [
                {
                    "exact_snippets": "Serious and/or uncontrolled preexisting medical condition",
                    "criterion": "preexisting medical condition",
                    "requirements": [
                        {
                            "requirement_type": "seriousness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of chest wall or ipsilateral breast radiation",
            "criterions": [
                {
                    "exact_snippets": "History of chest wall ... radiation",
                    "criterion": "chest wall radiation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... ipsilateral breast radiation",
                    "criterion": "ipsilateral breast radiation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "systolic blood pressure >190 mm Hg",
                    "criterion": "systolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 190,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "diastolic blood pressure >100 mm Hg",
                    "criterion": "diastolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindication for surgery",
            "criterions": [
                {
                    "exact_snippets": "Contraindication for surgery",
                    "criterion": "contraindication for surgery",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Needs neoadjuvant chemotherapy",
            "criterions": [
                {
                    "exact_snippets": "Needs neoadjuvant chemotherapy",
                    "criterion": "neoadjuvant chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "need",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of ipsilateral breast cancer",
            "criterions": [
                {
                    "exact_snippets": "History of ipsilateral breast cancer",
                    "criterion": "ipsilateral breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inflammatory breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Inflammatory breast cancer",
                    "criterion": "inflammatory breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with CDK4/6 inhibitors or aromatase inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with CDK4/6 inhibitors",
                    "criterion": "CDK4/6 inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with ... aromatase inhibitors",
                    "criterion": "aromatase inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has had major surgery within 14 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Has had major surgery within 14 days prior to enrollment",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allergy or hypersensitivity to any of the study drugs",
            "criterions": [
                {
                    "exact_snippets": "History of allergy or hypersensitivity to any of the study drugs",
                    "criterion": "allergy or hypersensitivity to study drugs",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}